Gingivitis Clinical Trial
Official title:
Influence of Probiotics on Clinical Parameters and GCF Levels of Interleukin-1β in Experimental Gingivitis: a Randomized Controlled Clinical Trial
| Verified date | August 2015 |
| Source | Marmara University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Turkey: Ethics Committee |
| Study type | Interventional |
The aim of this study was to evaluate the effects of probiotic yoghurt on the development of
gingival inflammation.
Fifty-one periodontally healthy individuals were given standard oral hygiene instructions
and randomly divided into two groups. The test group subjects (n=26) consumed probiotic
yoghurt containing Bifidobacterium animalis subsp. lactis and the control subjects (n=25)
natural yoghurt for 28 days. Following yoghurt consumption, mechanical plaque control was
interrupted for the next 5 days in both groups. Gingival crevicular fluid (GCF) samples and
clinical data (consisted of plaque and gingival indices, probing depth, bleeding on probing)
were collected at baseline, after 28 and 33 days. Interleukin-1β levels were determined in
GCF by ELISA.
| Status | Completed |
| Enrollment | 51 |
| Est. completion date | May 2012 |
| Est. primary completion date | May 2012 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 16 Years to 26 Years |
| Eligibility |
Inclusion Criteria: - No or minimal clinical signs of gingival inflammation - Gingival Index = 1 - No probing depth (Probing depth > 3 mm) - No approximal attachment loss > 2 mm - Non smokers Exclusion Criteria: - Systemic diseases - Antibiotics and anti-inflammatory drugs within 3 months before the study - Untreated caries lesions or local retention factors - Mouth-breathing - Allergies - Previous probiotic supplements in diet |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention
| Country | Name | City | State |
|---|---|---|---|
| Turkey | Marmara University, Faculty of Dentistry, Department of Periodontology | Istanbul | Sisli/Nisantasi |
| Lead Sponsor | Collaborator |
|---|---|
| Marmara University |
Turkey,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Probing Depth | Probing depth is defined as the distance from the free gingival margin to the bottom of the periodontal pocket. | 33 days after yoghurt consumption | Yes |
| Other | Gingival crevicular fluid Interleukin-1beta levels | 33 days after yoghurt consumption | Yes | |
| Primary | Bleeding on probing | Bleeding on probing is defined as presence of bleeding from gingival sulcus during the probing of this area via periodontal probe. | 33 days after yoghurt consumption | Yes |
| Secondary | Gingival Index | Each of the buccal, mesial, lingual and distal surfaces of the gingival tissues is given a score of 0-3. (0 = Normal gingiva. 1 = Mild inflammation - slight change in color, slight edema. No bleeding on probing. 2. Moderate inflammation - redness, edema and glazing. Bleeding on probing. 3. Severe inflammation -marked redness and edema.) | 33 days after yoghurt consumption | Yes |
| Secondary | Plaque Index | Each of the four surfaces of the teeth (buccal, lingual, mesial and distal) is given a score from 0-3. (0 = No plaque in the gingival area. 1 = A film of plaque adhering to the free gingival margin and adjacent area of the tooth. The plaque may only be recognized by running a probe across the tooth surface. 2 = Moderate accumulation of soft deposits within the gingival pocket, on the gingival margin and/or adjacent tooth surface, which can be seen by the naked eye. 3 = Abundance of soft matter within the gingival pocket and/or on the gingival margin and adjacent tooth surface. Tendency to spontaneous bleeding.) | 33 days after yoghurt consumption | Yes |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05568290 -
Interleukin-38 Levels in Individuals With Periodontitis
|
||
| Completed |
NCT04402996 -
Meteorin-like Levels in Individuals With Periodontitis
|
||
| Not yet recruiting |
NCT06016023 -
Evaluation of Macrophage Inflammatory Protein-1α as a Periodontal Disease Biomarker
|
||
| Not yet recruiting |
NCT05497895 -
The Assessment of Clinical Efficacy of Topical Application of 5% Thymoquinone Gel for Gingivitis Patients
|
Early Phase 1 | |
| Completed |
NCT02552589 -
Effect of Toothpaste on the Reduction of Plaque and Inflammation
|
N/A | |
| Completed |
NCT02633345 -
Effects on Tablets Containing Probiotic Candidate Strains
|
N/A | |
| Completed |
NCT02884817 -
Essential Oil+ELA, Plaque and Gingivitis
|
Phase 4 | |
| Unknown status |
NCT01956656 -
Efficacy Of Lotus Leaves In Management Of Plaque Induced Gingivitis
|
N/A | |
| Completed |
NCT02980497 -
Antiplaque/Antigingivitis Efficacy of Essential Oil Mouthrinses in Six-Month Study
|
N/A | |
| Completed |
NCT02515929 -
Prospective Double-Blind Randomized Controlled Clinical Trial in the Gingivitis Prevention With OPCs
|
Phase 4 | |
| Completed |
NCT02235532 -
Effects of Aloe Vera Toothpaste on Periodontal Parameters
|
N/A | |
| Completed |
NCT02508987 -
Obesity and Oxidative Stress in Patients With Different Periodontal Status
|
N/A | |
| Completed |
NCT01941797 -
Experimental Peri-implant Mucositis in Humans
|
N/A | |
| Completed |
NCT01593540 -
Clinical Examination of Metal Free Interdental Brushes
|
Phase 4 | |
| Unknown status |
NCT01197105 -
Evaluation Study of a Mouthwash Based on Schinus Terebinthifolius to Treat Gingivitis in Children
|
Phase 1/Phase 2 | |
| Completed |
NCT01236963 -
Essential Oils Mouth Rinse and Dental Floss: Efficacy on Interproximal Gingivitis and Dental Plaque Accumulation
|
N/A | |
| Completed |
NCT02102295 -
Effects of Antioxidant Dentifrice on Gingivitis
|
Phase 3 | |
| Completed |
NCT06140784 -
A Clinical Study to Assess the Gingivitis and Plaque Effects of Various Dentifrices
|
N/A | |
| Completed |
NCT02937636 -
To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population
|
N/A | |
| Completed |
NCT06212908 -
Assessment of Periodontal Therapy and Biofilm Management in Breast Cancer
|
N/A |